A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
R
S
T
U
V
W
Heart, front view
Heart, front view
Lungs
Lungs
Thoracic organs
Thoracic organs

Heart-and-lung transplant
Definition:
This surgery replaces a diseased heart and lungs with a healthy heart and lungs from a human donor.

Alternative Names:
Transplant - heart and lungs

Description:
Heart-and-lung transplant operations have been performed since 1980 in the United States. In 1997, approximately 150 of these operations were performed. The donated heart and lungs are from a human who has been declared brain-dead, but remains on life-support. Tissue matches must be performed to assure the patient's best chance of not rejecting the transplanted organs.

While the patient is deep asleep and pain-free (general anesthesia), an incision is made through the breast bone (sternum). Tubes are used to re-route the blood to a heart-lung bypass machine. This keeps the blood oxygenated and circulating during the surgery.

The patient's heart and lungs are removed, and the donor heart and lungs are stitched into place.
Indications:
Heart-lung transplant may be recommended for patients with:Heart-and-lung transplants are not recommended for patients who have decreased kidney or liver function, insulin dependent diabetes mellitus, or other serious diseases.
Risks:
Risks for any anesthesia are: Risks for any surgery are: Additional risks of transplant includes:
Expectations after surgery:

A heart-and-lung transplant prolongs the life of a patient who otherwise would die. The operation is done only in patients where there is a very good chance of success. While long-term outcomes are unknown at this time, 5 year survival is approximately 40%-50%.

As with all major organ transplants, the problems are finding a donor, preventing rejection, and the cost of the surgery and anti-rejection medications.

Finding a donor for heart-lung transplant can be difficult. The donated organs must come from a person who has been declared brain-dead, but is still on life-support, while the patient is still in healthy-enough condition to survive the surgery.

Preventing rejection is an ongoing process. The body's immune system considers the transplanted organs as invaders (much like an infection), and fights them.

To prevent rejection, organ transplant patients must take anti-rejection (immunosuppression) drugs (such as cyclosporine and corticosteroids) that reduce (suppress) the body's immune response and reduce the chance of rejection. These drugs also reduce the body's natural ability to fight off various infections.
Convalescence:
An extended hospital stay should be expected. The recovery period is about 6 months. Frequent check-ups with blood tests and X-ray tests will be necessary for years.
Review Date: 1/22/2002
Reviewed By: John A. Daller, M.D. Ph.D., Department of Surgery, University of Texas Medical Branch, Galveston, TX. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 2003 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com